Managers / Q4 2024 · view latest →
ACT Advisors, LLC.
CIK 0001842554 · 521 COLLEGE STREET, ASHEVILLE, NC, 28801 · 8283982802
Summary
Act Advisors, LLC. reported $186M in U.S.-listed holdings across 58 positions for Q4 2024.
Its largest position, Ishares Tr, represents 15.8% of the portfolio.
Compared with Q3 2024, the fund opened 13 new positions and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 94.4% · $175M
- Common Stock · 5.5% · $10M
- Other · 0.0% · $46,689
Quarter-over-Quarter Changes full breakdown →
vs Q3 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| INVESCO EXCH TRADED FD TR II | NEW | +129.3K | 129.3K | +$27M | $27M |
| SSGA ACTIVE ETF TR | NEW | +190.5K | 190.5K | +$8M | $8M |
| INNOVATOR ETFS TRUST | NEW | +10.8K | 10.8K | +$414,244 | $414,244 |
| JPMJPMORGAN CHASE & CO. | NEW | +1.0K | 1.0K | +$245,609 | $245,609 |
| WMTWALMART INC | NEW | +2.4K | 2.4K | +$215,578 | $215,578 |
| CALIBERCOS INC | NEW | +30.2K | 30.2K | +$21,080 | $21,080 |
| ACXPEURACURX PHARMACEUTICALS INC | NEW | +21.3K | 21.3K | +$17,325 | $17,325 |
| BIODESIX INC | NEW | +11.2K | 11.2K | +$17,087 | $17,087 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ISHARES TR | CORE S&P500 ETF · MSCI USA MIN VOL · MSCI USA MMENTM · CORE US AGGBD ET · CORE S&P MCP ETF | 18.19% | $34M | 91.9K |
| 2 | INVESCO EXCH TRADED FD TR II | NASDAQ 100 ETF · SHORT TERM TREAS · S&P MIDCP LOW | 16.09% | $30M | 157.0K |
| 3 | WISDOMTREE TR | US QTLY DIV GRT · US EFFICIENT COR | 12.47% | $23M | 293.0K |
| 4 | DFAUDIMENSIONAL ETF TRUSThistory → | US CORE EQT MKT | 11.37% | $21M | 521.8K |
| 5 | INVESCO EXCHANGE TRADED FD T | S&P500 QUALITY | 11.17% | $21M | 309.6K |
| 6 | SPDR SER TR | BBG CONV SEC ETF · PORTFOLIO S&P500 · NUVEEN BLOOMBERG · PORTFOLIO S&P600 | 6.85% | $13M | 198.0K |
| 7 | J P MORGAN EXCHANGE TRADED F | ULTRA SHRT ETF · BETABUILDERS US | 6.58% | $12M | 234.8K |
| 8 | SSGA ACTIVE ETF TR | BLACKSTONE SENR | 4.28% | $8M | 190.5K |
| 9 | VANGUARD INDEX FDS | TOTAL STK MKT · LARGE CAP ETF | 4.10% | $8M | 26.4K |
| 10 | SPDR INDEX SHS FDS | PORTFOLIO DEVLPD · PORTFOLIO EMG MK | 1.18% | $2M | 62.7K |
| 11 | AAPLAPPLE INChistory → | COM | 1.07% | $2M | 8.0K |
| 12 | MSFTMICROSOFT CORP | COM | 0.87% | $2M | 3.8K |
| 13 | INNOVATOR ETFS TRUST | US EQT ULTRA BF · DEFINED WLT SHLD · US EQTY PWR BUF | 0.74% | $1M | 39.3K |
| 14 | NVDANVIDIA CORPORATION | COM | 0.63% | $1M | 8.7K |
| 15 | FLIAFRANKLIN TEMPLETON ETF TR | INTL AGGREGTE BD | 0.53% | $979,611 | 48.3K |
| 16 | INVESCO EXCH TRD SLF IDX FD | RUSL 1000 DYNM | 0.52% | $964,274 | 17.8K |
| 17 | KOCOCA COLA CO | COM | 0.44% | $825,489 | 13.3K |
| 18 | AMZNAMAZON COM INC | COM | 0.37% | $687,349 | 3.1K |
| 19 | GOOGLALPHABET INC | CAP STK CL A · CAP STK CL C | 0.37% | $678,855 | 3.6K |
| 20 | METAMETA PLATFORMS INC | CL A | 0.35% | $653,576 | 1.1K |
| 21 | PIMCO ETF TR | ACTIVE BD ETF | 0.26% | $483,114 | 5.3K |
| 22 | TSLATESLA INC | COM | 0.21% | $396,571 | 982 |
| 23 | AVGOBROADCOM INC | COM | 0.21% | $394,656 | 1.7K |
| 24 | BRK/BBERKSHIRE HATHAWAY INC DEL | CL B NEW | 0.19% | $359,904 | 794 |
| 25 | HDHOME DEPOT INC | COM | 0.13% | $250,424 | 644 |
| 26 | LLYELI LILLY & CO | COM | 0.13% | $245,624 | 318 |
| 27 | JPMJPMORGAN CHASE & CO. | COM | 0.13% | $245,609 | 1.0K |
| 28 | BABOEING CO | COM | 0.13% | $242,313 | 1.4K |
| 29 | 4I1PHILIP MORRIS INTL INC | COM | 0.13% | $233,324 | 1.9K |
| 30 | FIRST TR VALUE LINE DIVID IN | SHS | 0.12% | $219,534 | 5.0K |
| 31 | WMTWALMART INC | COM | 0.12% | $215,578 | 2.4K |
| 32 | AXD2HERON THERAPEUTICS INC | COM | 0.02% | $39,139 | 25.6K |
| 33 | CALIBERCOS INC | COM CL A | 0.01% | $21,080 | 30.2K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $235M | 78 | Apr 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $254M | 65 | Jan 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $248M | 73 | Oct 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $216M | 62 | Jul 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $184M | 57 | Apr 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $186M | 58 | Jan 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $212M | 52 | Oct 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $192M | 48 | Jul 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $182M | 46 | Apr 17, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $175M | 44 | Jan 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $161M | 37 | Oct 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $151M | 28 | Jul 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $155M | 28 | Apr 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $157M | 35 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $143M | 28 | Oct 6, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $136M | 27 | Jul 20, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $155M | 26 | Apr 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $136M | 33 | Jan 21, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $130M | 32 | Oct 18, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $132M | 32 | Jul 7, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $127M | 31 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $110M | 29 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.